首页> 外文期刊>Urology >Advancing Treatment Strategies in Metastatic Castration-resistant Prostate Cancer: The Urologists Role
【24h】

Advancing Treatment Strategies in Metastatic Castration-resistant Prostate Cancer: The Urologists Role

机译:转移性去势抵抗性前列腺癌的先进治疗策略:泌尿科医师的作用

获取原文
获取原文并翻译 | 示例
           

摘要

In this interactive CME web-based activity, a faculty of experts describes comprehensive monitoring parameters that may indicate efficacy of therapy or help guide management decisions for the treatment of metastatic castration-resistant prostate cancer (online access: https://ce.paradigmmc.com/a/19339PAmVzYF). Participants learn to recognize the differences among agents for metastatic castration-resistant prostate cancer in order to make evidence-based, individualized treatment decisions for their patients and to evaluate successful multidisciplinary models of care. (C) 2016 Elsevier Inc.
机译:在此基于CME的交互式网络互动活动中,专家团队描述了全面的监控参数,这些参数可能指示治疗功效或帮助指导管理决策,以治疗转移性去势抵抗性前列腺癌(在线访问:https://ce.paradigmmc。 com / a / 19339PAmVzYF)。参与者学会认识到转移去势抵抗性前列腺癌的治疗药物之间的差异,以便为患者制定基于证据的个性化治疗决策,并评估成功的多学科治疗模型。 (C)2016爱思唯尔公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号